Molecular serotyping of clinical strains of Haemophilus (Glaesserella) parasuis brings new insights regarding Glässer's disease outbreaks in Brazil
- PMID: 31198621
- PMCID: PMC6535215
- DOI: 10.7717/peerj.6817
Molecular serotyping of clinical strains of Haemophilus (Glaesserella) parasuis brings new insights regarding Glässer's disease outbreaks in Brazil
Abstract
Glässer's disease (GD) is an important infectious disease of swine caused by Haemophilus (Glaesserella) parasuis. Vaccination with inactivated whole cell vaccines is the major approach for prevention of H. parasuis infection worldwide, but the immunity induced is predominantly against the specific polysaccharide capsule. As a consequence, the available vaccines may not induce adequate protection against the field strains, when the capsules present in the vaccine strains are different from those in strains isolated from the farms. Therefore, it is crucial to map H. parasuis serovars associated with regional outbreaks so that appropriate bacterin vaccines can be developed and distributed for prevention of infection. In this study, 459 H. parasuis field strains isolated from different Glässer's disease outbreaks that occurred in 10 different Brazilian States were analyzed for serotype using PCR-based approaches. Surprisingly, non-typeable (NT) strains were the second most prevalent group of field strains and along with serovars 4, 5 and 1 comprised more than 70% of the isolates. A PCR-based approach designed to amplify the entire polysaccharide capsule locus revealed 9 different band patterns in the NT strains, and 75% of the NT strains belonged to three clusters, suggesting that a number of new serovars are responsible for a substantial proportion of disease. These results indicate that commercially available vaccines in Brazil do not cover the most prevalent H. parasuis serovars associated with GD.
Keywords: Brazil; Disease mapping; Haemophilus parasuis; Serovars; Typification; Vaccines.
Conflict of interest statement
Dr. Anthony B. Schryvers is a stakeholder in Engineered Antigens Inc. that holds IP related to vaccines against human and veterinary pathogens, including H. parasuis, but this had no influence on this study. None of the authors of this paper has a financial or personal relationship with private organizations that could inappropriately influence or bias the content of the paper.
Figures




Similar articles
-
TbpB-based oral mucosal vaccine provides heterologous protection against Glässer's disease caused by different serovars of Spanish field isolates of Glaesserella parasuis.Porcine Health Manag. 2024 Nov 28;10(1):57. doi: 10.1186/s40813-024-00404-7. Porcine Health Manag. 2024. PMID: 39609907 Free PMC article.
-
Application of ERIC-PCR for the comparison of isolates of Haemophilus parasuis.Aust Vet J. 2000 Dec;78(12):846-9. doi: 10.1111/j.1751-0813.2000.tb10507.x. Aust Vet J. 2000. PMID: 11194474
-
Importance of strain selection in the generation of heterologous immunity to Glaesserella (Haemophilus) parasuis.Vet Immunol Immunopathol. 2021 Apr;234:110205. doi: 10.1016/j.vetimm.2021.110205. Epub 2021 Feb 12. Vet Immunol Immunopathol. 2021. PMID: 33636545
-
Research progress into the principles and methods underlying capsular typing of Glaesserella parasuis.Vet Res. 2024 Oct 15;55(1):137. doi: 10.1186/s13567-024-01395-7. Vet Res. 2024. PMID: 39407326 Free PMC article.
-
Haemophilus parasuis vaccines.Vet Immunol Immunopathol. 2016 Nov 1;180:53-58. doi: 10.1016/j.vetimm.2016.09.002. Epub 2016 Sep 9. Vet Immunol Immunopathol. 2016. PMID: 27692096 Review.
Cited by
-
Serotypes, virulence factors and multilocus sequence typing of Glaesserella parasuis from diseased pigs in Taiwan.PeerJ. 2023 Sep 29;11:e15823. doi: 10.7717/peerj.15823. eCollection 2023. PeerJ. 2023. PMID: 37790626 Free PMC article.
-
Distribution of Actinobacillus pleuropneumoniae (from 2015 to June 2020) and Glaesserella parasuis (from 2017 to June 2020) serotypes isolated from diseased pigs in Quebec.Can Vet J. 2020 Dec;61(12):1261-1263. Can Vet J. 2020. PMID: 33299240 Free PMC article. No abstract available.
-
Development and Validation of a Loop-Mediated Isothermal Amplification (LAMP) Assay for Rapid Detection of Glaesserella (Haemophilus) parasuis.Microorganisms. 2020 Dec 25;9(1):41. doi: 10.3390/microorganisms9010041. Microorganisms. 2020. PMID: 33375599 Free PMC article.
-
Metal Ion Periplasmic-Binding Protein YfeA of Glaesserella parasuis Induces the Secretion of Pro-Inflammatory Cytokines of Macrophages via MAPK and NF-κB Signaling through TLR2 and TLR4.Int J Mol Sci. 2022 Aug 25;23(17):9627. doi: 10.3390/ijms23179627. Int J Mol Sci. 2022. PMID: 36077023 Free PMC article.
-
Serotyping and pathotyping of Glaesserella parasuis isolated 2012-2019 in Germany comparing different PCR-based methods.Vet Res. 2020 Nov 17;51(1):137. doi: 10.1186/s13567-020-00862-1. Vet Res. 2020. PMID: 33203465 Free PMC article.
References
-
- Barasuol BM, Guizzo JA, Fegan JE, Martinez-Martinez S, Rodriguez-Ferri EF, Gutierrez-Martin CB, Kreutz LC, Schryvers AB, Frandoloso R. New insights about functional and cross-reactive properties of antibodies generated against recombinant TbpBs of Haemophilus parasuis. Scientific Reports. 2017;7:10377. doi: 10.1038/s41598-017-10627-0. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials